Association Between Cytokine Profile and Transcription Factors Produced by T-cell Subsets in Early- and Late-onset Pre-eclampsia
Overview
Authors
Affiliations
Pre-eclampsia (PE) is an obstetric pathology characterized by abnormal activation of the innate and adaptive immune systems dependent on the imbalance of T helper subsets. The present study aimed to evaluate the gene and protein expression of T helper type 1 (Th1)/Th2/Th17/regulatory T (Treg) cell transcription factors in peripheral blood lymphocytes from pregnant women with PE employing quantitative RT-PCR and flow cytometry techniques, as well as the cytokine profile produced by these CD4 T-cell subsets in the plasma of pregnant women with PE, classified as early-onset PE (n = 20), late-onset PE (n = 20) and normotensive pregnant women (n = 20). Results showed a higher percentage of CD4 T cells expressing the RORc transcription factor (Th17) and a lower percentage of cells expressing FoxP3 (Treg) in women with early-onset PE compared with late-onset PE and normotensive groups. A lower gene expression of GATA-3 transcription factor was detected in cells of women with early-onset PE compared with the late-onset PE group. Endogenous plasma levels of interleukin-6 (IL-6), IL-17 and tumour necrosis factor-α were significantly higher in the early-onset PE group than in the late-onset PE and normotensive groups, whereas IL-4 (Th2 profile) and IL-22 (Th17 profile), were not significantly different between the studied groups. The endogenous levels of transforming growth factor-β and IL-10 were significantly lower in the pre-eclamptic than in the normotensive groups of the same gestational age, with a significant difference between early- and late-onset PE. The results show that in women with PE there is an imbalance between inflammatory and anti-inflammatory profiles in CD4 T-cell subsets, with polarization to Th17 profiles in the early-onset PE, considered as the severe form of PE.
Plug A, Barenbrug L, Moerings B, de Jong E, van der Molen R J Transl Autoimmun. 2025; 10:100279.
PMID: 40035074 PMC: 11874717. DOI: 10.1016/j.jtauto.2025.100279.
A comprehensive review of the roles of T-cell immunity in preeclampsia.
Peng X, Chinwe Oluchi-Amaka I, Kwak-Kim J, Yang X Front Immunol. 2025; 16:1476123.
PMID: 39981257 PMC: 11841438. DOI: 10.3389/fimmu.2025.1476123.
Importance of STAT3 signaling in preeclampsia (Review).
Marzioni D, Piani F, Di Simone N, Giannubilo S, Ciavattini A, Tossetta G Int J Mol Med. 2025; 55(4).
PMID: 39918020 PMC: 11878484. DOI: 10.3892/ijmm.2025.5499.
A Narrative Review on the Pathophysiology of Preeclampsia.
Torres-Torres J, Espino-Y-Sosa S, Martinez-Portilla R, Borboa-Olivares H, Estrada-Gutierrez G, Acevedo-Gallegos S Int J Mol Sci. 2024; 25(14).
PMID: 39062815 PMC: 11277207. DOI: 10.3390/ijms25147569.
Gajic M, Schroder-Heurich B, Mayer-Pickel K Front Pharmacol. 2024; 15:1298928.
PMID: 38375029 PMC: 10875033. DOI: 10.3389/fphar.2024.1298928.